Fungal Septomics

Aldejohann AM, Menner C, Thielemann N, Martin R, Walther G, Kurzai O (2024) In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrob Agents Chemother 68(2), e0132423.

Banz M, Stallmach A, Gaßler N, Schulze PC, Fritzenwanger M, Cornely O, Kurzai O, Pletz MW (2024) Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis. Infection 52(2), 685-690.

Heilig L, Fariha N, Trinks N, Aimanianda V, Wong SSW, Fontaine T, Terpitz U, Strobel L, Lemauff F, Sheppard D, Schaeuble S, Kurzai O, Hünniger K, Weiss E, Vargas M, Howell PL, Panagiotou G, Wurster S, Einsele H, Löffler J (2024) CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan. PLOS Pathog 20(6), e1012315.

Krone M, Rauschenberger V, Blaschke V, Claus H, Kurzai O, Kampmeier S (2024) Ralstonia pickettii bloodstream infections with potential genomic link to internationally distributed contaminated saline solution, Germany, October 2023. Euro Surveill 29(3), 2400010.

Salmanton-García J, Simon M, Groll AH, Kurzai O, Lahmer T, Lehrnbecher T, Schroeder M, Cornely OA, Stemler J (2024) Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany. JAC Antimicrob Resist 6(3), dlae083.

Schrenker B, Zimmermann A, Koch T, Walther G, Martin R, Kampik D, Kurzai O, Theuersbacher J (2024) Polyhexanide based contact lens storage fluids frequently exhibit insufficient antifungal activity against Fusarium species. Int J Med Microbiol 314, 151602.

Seidel D, Sal E, Nacov JA, Cornely OA, Kurzai O (2024) [Mucormycosis in the time of COVID-19: risks and challenges]. Dtsch Med Wochenschr 149(10), 569-578. (Review)

Stieber H, Junghanns L, Wilhelm H, Batliner M, Aldejohann AM, Kurzai O, Martin R (2024) The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B. Mycoses 67(4), e13723.

Yuu EY, Bührer C, Eckmanns T, Fulde M, Herz M, Kurzai O, Lindstedt C, Panagiotou G, Piro VC, Radonic A, Renard BY, Reuss A, Leal Siliceo S, Thielemann N, Thürmer A, van Vorst K, Wieler LH, Haller S^# (2024) The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis. Gut Pathog 16(1), 27.

Aldejohann AM, Martin R, Hecht J, Haller S, Rickerts V, Walther G, Eckmanns T, Kurzai O (2023) Rise in Candida Auris cases and first nosocomial transmissions in Germany. Dtsch Arztebl Int 120(27-28), 447-478.